High Fas ligand expression on lymphocytes in lesions of ulcerative colitis

Gut

Volumn 43, Issue 1, 1998, Pages 48-55

  Ueyama, H ^a   Kiyohara, T ^a   Sawada, N ^a   Isozaki, K ^a   Kitamura, S ^a   Kondo, S ^a   Miyagawa, J ^a   Kanayama, S ^a   Shinomura, Y ^a   Ishikawa, H ^b   Ohtani, T ^b   Nezu, R ^a   Nagata, S ^a   Matsuzawa, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Apoptosis; Fas ligand; Reverse transcription polymerase chain reaction; T lymphocytes; Ulcerative colitis

Indexed keywords

CD3 ANTIGEN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LAMINA PROPRIA; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

EID: 7344245990     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.1.48     Document Type: Article

References (37)

1. Das KM, Dubin R, Nagai T. Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci USA 1978;75:4528-32.
2. Targan S, Saxon A, Landers C, et al. Serum anti-neutrophil cytoplasmic antibodies distinguish ulcerative colitis from Crohn's disease patients [abstract]. Gastroenterology 1989; 109:96A505.
3. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
4. Kühn R, Löhler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
5. Mombaerts E, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:275-82.
6. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
7. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-62.
8. Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
9. Gruss HJ, Dower S. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphoma. Blood 1995;85:3378-404.
10. Mogil RJ, Radvanyi L, Gonzalez-Quintial R, et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol 1995;7:1451-8.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356: 314-17.
12. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
13. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1996;268:1347-9.
14. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81: 935-46.
15. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364: 806-9.
16. Galle PR, Hoffmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
17. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-13.
18. Hanabuchi S, Koyanagi M, Kawasaki A, et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994;91:4930-4.
19. Leithäuser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo-I, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69: 415-29.
20. Kondo S, Imamura I, Shinomura Y, et al. Determination of histidine decarboxylase mRNA in various rat tissues by the polymerase chain reaction. Inflamm Res 1995;44:111-15.
21. Kondo S, Shinomura Y, Kanayama S, et al. Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem Biophys Res Commun 1995;210:960-5.
22. Matts F. The value of rectal biopsy in the diagnosis of ulcerative colitis. QJM 1961;120:393-407.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Takahashi T, Tanaka M, Inazawa J, et al. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994;6:1567-74.
25. Hirota S, Itoh A, Morii E, et al. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization histochemistry. Molecular Brain Research 1992;15:47-54.
26. Fais S, Capobianchi MR, Pallone F, et al. Spontaneous release of interferon γ by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon γ inducers. Gut 1991;32:403-7.
27. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum Nat Med 1996;2:317-22.
28. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993;46:118-22.
29. Murch SH, Braegger CP, Sessa WC. High endothelin-I immunoreactivity in Crohn's disease and ulcerative colitis. Lancet 1992;339:381-5.
30. Watanabe M, Tsuru S, Zinnaka Y, et al. Demonstration and characterization of immunosupressive factors in sera from patients with Crohn's disease. J Clin Lab Immunol 1985;17: 13-19.
31. Allison MC, Cornwall S, Poulter LW, et al. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988;29:1531-8.
32. De Maria R, Boirivant M, Cifone MG, et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest 1996;97:316-22.
33. Möller P, Walczak H, Riedl S, et al. Paneth cells express high levels of CD95 ligand transcripts. A unique property among gastrointestinal epithelia. Am J Pathol 1996;149:9-13.
34. Abreu-Martin MT, Vidrich A, Lynch DH, et al. Divergent induction of apoptosis and IL-8 secretion on HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 1995;155:4147-54.
35. Larsen CG, Anderson AO, Appella E, et al. The neutrophil-activating protein (NAP-1) is also chemotactic for lymphocytes. Science 1989;243:1464-6.
36. Tanaka S, Robinson EA, Yoshimura T, et al. Synthesis and biological characterization of monocyte-derived neutrophil chemotactic factor. FEBS Lett 1988;236:467-70.
37. Lindley I, Aschauer H, Seifert JM. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 1988;85:9199-203.